Clinical Stage Therapeutics Group Raises $53M
Massachusetts-based Finch Therapeutics Group Inc. on Thursday announced it received $53 million during its latest financing round, which it will use to advance its treatments for a common hospital-linked bacterial infection...To view the full article, register now.
Already a subscriber? Click here to view full article